2025 revenue consensus $473.05M.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed reports Q3 EPS ($1.75), consensus ($1.37)
- Insmed price target raised to $196 from $165 at Mizuho
- Insmed assumed with an Overweight at Cantor Fitzgerald
- INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment